Literature DB >> 32897457

Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease.

Xu Teng1, Yingying Qi1, Jing Li1, Jie Wu2,3.   

Abstract

The objective was to investigate the effect of exclusive enteral nutrition (EEN) on T helper (Th) 17 cells by observing the effects of EEN on colon and serum interleukin (IL)-17A levels in juvenile inflammatory bowel disease (IBD) rat models and to reveal the potential mechanism of the therapeutic effect of EEN on IBD. ATNBS-induced IBD rat model was established. Feeding Peptison, a type of enteric nutrition (EN) for EEN-IBD group and EEN group, normal feed for IBD model group and control group for six consecutive days. Four groups of juvenile rats were sacrificed on day 7. The pathology of the intestinal mucosa was examined, the expression of IL-17A in serum was detected by ELISA, and the expression of IL-17A in intestinal tissue was detected by both western blot and real-time PCR (RT-PCR). Diarrhea, bloody stools, and weight loss were found in both the IBD group and the EEN-IBD group. After 5 days of EEN feeding, the stool characteristics, and blood in the stools of the rats in the EEN-IBD group were significantly relieved compared with those of the IBD group. There was no significant difference in the body mass growth rate between the IBD group and EEN-IBD group (P > 0.05). The growth rate of the EEN group was 51.29 ± 3.61%, which was significantly lower than that of the control group (60.17 ± 9.32%) with P < 0.05. The disease activity index (DAI) score of the EEN-IBD group was significantly lower than that of the IBD group (P < 0.05). In the IBD group, colonic congestion and edema were obvious, scattered ulcers were observed, and the intestinal mucosa had a large amount of inflammatory cell infiltration. In the EEN-IBD group, the intestinal mucosa was slightly congested and a small amount of inflammatory cell infiltrated. The serum IL-17A expression level in the IBD group was significantly higher than in the EEN-IBD group, control group, and EEN group (P < 0.05). Both the gene and protein expressions of IL-17A in the intestinal tissue of the EEN-IBD group were significantly lower than in the IBD group (P < 0.01), and it was significantly higher in the IBD group than in the control and EEN groups (P < 0.01). EEN effectively reduced the intestinal inflammation in the juvenile rats with IBD. The mechanism could be related to the regulation of Th17 cells and the expression of the corresponding cytokine, IL-17A. EEN may play a role in downregulating the expression of IL-17A in the intestinal mucosa.

Entities:  

Keywords:  EEN; IBD; IL-17A; Th17; rat

Year:  2020        PMID: 32897457     DOI: 10.1007/s10753-020-01328-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  16 in total

Review 1.  Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.

Authors:  S Brand
Journal:  Gut       Date:  2009-08       Impact factor: 23.059

2.  Digoxin Attenuates Murine Experimental Colitis by Downregulating Th17-related Cytokines.

Authors:  Shinya Tani; Ryosuke Takano; Satoshi Tamura; Shinji Oishi; Moriya Iwaizumi; Yasushi Hamaya; Kosuke Takagaki; Toshi Nagata; Shintaro Seto; Toshinobu Horii; Isao Kosugi; Toshihide Iwashita; Satoshi Osawa; Takahisa Furuta; Hiroaki Miyajima; Ken Sugimoto
Journal:  Inflamm Bowel Dis       Date:  2017-05       Impact factor: 5.325

Review 3.  Mucosal healing in inflammatory bowel diseases: a systematic review.

Authors:  Markus F Neurath; Simon P L Travis
Journal:  Gut       Date:  2012-07-27       Impact factor: 23.059

Review 4.  Mechanisms of Disease: Inflammatory Bowel Diseases.

Authors:  Guilherme Piovezani Ramos; Konstantinos A Papadakis
Journal:  Mayo Clin Proc       Date:  2019-01       Impact factor: 7.616

Review 5.  Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Jonas Mudter
Journal:  Inflamm Bowel Dis       Date:  2011-03-04       Impact factor: 5.325

6.  Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)).

Authors:  N Hamamoto; K Maemura; I Hirata; M Murano; S Sasaki; K Katsu
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

7.  Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai.

Authors:  Xin-qiong Wang; Yin Zhang; Chun-di Xu; Li-rong Jiang; Ying Huang; Hui-min Du; Xiao-jin Wang
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

8.  Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.

Authors:  Anna-Maria Globig; Nadine Hennecke; Bianca Martin; Maximilian Seidl; Günther Ruf; Peter Hasselblatt; Robert Thimme; Bertram Bengsch
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 9.  Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.

Authors:  Marco Gasparetto; Graziella Guariso
Journal:  Gastroenterol Res Pract       Date:  2013-12-24       Impact factor: 2.260

Review 10.  Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.

Authors:  Berrie Meijer; Chris Jj Mulder; Godefridus J Peters; Adriaan A van Bodegraven; Nanne Kh de Boer
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.